CompletedNot Applicable

Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)

Italy1,101 participantsStarted 2015-04-28

Plain-language summary

ELASTOVOD is a prospective multicenter study, involving several centers of Onco-haematology in Italy. Investigators perform hepatic elastographic measurements (with Transient Elastography, ARFI or 2D-SWE) on patients undergoing HSCT, at baseline before transplantation (T0) and at T1/T2/T3 after HSCT (+9/10, +15/17, +22/24). SOS/VOD diagnosis was performed according to clinical criteria.

Who can participate

Age range3 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * male or female patients * age between 3 and 70 * patients suffering from an onco-hematological disease that have an indication for either allogenic or autologous hematopoietic stem cells transplantation * obtaining of informed consent Exclusion Criteria: * pathological obesity (BMI \>40) * pacemaker of implantable defibrillator * presence of ascites at baseline

What they're measuring

Diagnostic Role of Liver Stiffness Measurement in SOS/VOD development

Timeframe: From HSCT to 30 days after HSCT

Trial details

NCT IDNCT03426358

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12

View on ClinicalTrials.gov More Veno Occlusive Disease, Hepatic trials